Z8A-31681-17999
2 vaccinations
17 coded responses
25 check-ins
17 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 600 / IL
- Registered
- 2021-03-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-29
Registered in v-safe
-
2021-03-29
Dose 1 — Pfizer-BioNTech
-
2021-03-29
Survey response — day 0, dose 1MedDRA: Headache, Migraine, Nausea — Feeling: Good · Headache, NauseaFree text: Headache and nausea are related to a chronic migraine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Survey response — days 1–6 daily, dose 1MedDRA: Condition aggravated, Headache, Migraine, Pre-existing disease — Feeling: Good · Site: Pain · HeadacheFree text: Headache is due to chronic, severe migraines.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Survey response — days 1–6 daily, dose 1MedDRA: Migraine — Feeling: Good · Headache, NauseaFree text: Chronic severe migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Survey response — days 1–6 daily, dose 1MedDRA: Headache, Migraine, Nausea — Feeling: Good · Headache, NauseaFree text: Headache and nausea are due to chronic migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Survey response — days 1–6 daily, dose 1MedDRA: Migraine — Feeling: Good · Headache, NauseaFree text: Due to chronic migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Survey response — days 1–6 daily, dose 1MedDRA: Migraine, Pre-existing disease — Feeling: Good · HeadacheFree text: Chronic severe migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-04
Survey response — days 1–6 daily, dose 1MedDRA: Headache, Migraine, Nausea — Feeling: Good · Headache, NauseaFree text: Headache and nausea due to chronic severe migraines.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Survey response — day 7, dose 1MedDRA: Headache, Nausea, Pre-existing disease — Feeling: Good · Headache, NauseaFree text: Headache and nausea due to chronic migraines.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-12
-
2021-04-19
Dose 2 — Pfizer-BioNTech
-
2021-04-19
Survey response — day 0, dose 2MedDRA: Migraine — Feeling: Good · HeadacheFree text: Chronic severe migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Survey response — days 1–6 daily, dose 2MedDRA: Headache — Feeling: Good · Headache, NauseaFree text: Symptoms due to chronic severe migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-21
Survey response — days 1–6 daily, dose 2MedDRA: Headache, Migraine — Feeling: Good · HeadacheFree text: Headache due to chronic severe migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Survey response — days 1–6 daily, dose 2MedDRA: Headache, Migraine, Pre-existing disease — Feeling: Good · HeadacheFree text: Headache related to chronic severe migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Survey response — days 1–6 daily, dose 2MedDRA: Migraine, Pre-existing disease — Feeling: Good · HeadacheFree text: I have chronic, severe migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-24
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease — Feeling: Good · Headache, NauseaFree text: Probably due to my chronic migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Headache, Migraine — Feeling: Good · HeadacheFree text: Headache probably related to chronic severe migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-26
Survey response — day 7, dose 2MedDRA: Headache, Migraine, Nausea — Feeling: Good · Headache, NauseaFree text: Headache and nausea likely due to chronic severe migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-03
- 2021-05-12
- 2021-05-17
- 2021-05-24
-
2021-05-31
Survey response — day 42, dose 2MedDRA: Anxiety, Depression, Migraine, Pain — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Depression and anxiety, migraines, chronic painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-31
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-19
- 2021-10-18
- 2022-04-14
- 2022-04-19
- 2022-04-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-29 | Pfizer-BioNTech | |
| 2 | 2021-04-19 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-31 | Unsuccessful |
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): Headache and nausea are related to a chronic migraine.
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Headache is due to chronic, severe migraines.
Systemic reaction (other): Chronic severe migraines
Systemic reaction (other): Headache and nausea are due to chronic migraines
Systemic reaction (other): Due to chronic migraines
Systemic reaction (other): Chronic severe migraines
Systemic reaction (other): Headache and nausea due to chronic severe migraines.
Release 6 — day 7, dose 1
Systemic reaction (other): Headache and nausea due to chronic migraines.
Release 7 — day 0, dose 2
Systemic reaction (other): Chronic severe migraines
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Symptoms due to chronic severe migraines
Systemic reaction (other): Headache due to chronic severe migraines
Systemic reaction (other): Headache related to chronic severe migraines
Systemic reaction (other): I have chronic, severe migraines
Systemic reaction (other): Probably due to my chronic migraines
Systemic reaction (other): Headache probably related to chronic severe migraines
Release 8 — day 7, dose 2
Systemic reaction (other): Headache and nausea likely due to chronic severe migraines
Release 8 — day 42, dose 2
Symptoms: Depression and anxiety, migraines, chronic pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | ✓ | ✓ | ✓ |
| SD | Depression | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release